Taiwan FDA registration d46e9ed7cb6f5d5279dddc599037fe93
Kuai'an nucleic acid amplification reaction reagent
TW: 快安核酸放大反應試劑
Taiwan·Risk Class 1·QIAGEN GMBH·Registered Feb 17, 2009 – Feb 17, 2014CancelledRegistration details
- Analysis ID
- d46e9ed7cb6f5d5279dddc599037fe93
- Customs Code
- DHA04400749200
Company information
- Manufacturer
- QIAGEN GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- TAIGEN BIOSCIENCE CORPORATION
Product details
- Intended Use
- Limited to the first level identification scope of "General Purpose Reaction Reagents (B.4010)" under the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4010 Reaction Reagents for General Purposes
- Import Information
- import
Dates and status
- Registration Date
- Feb 17, 2009
- Expiry Date
- Feb 17, 2014
- Cancellation Date
- Sep 26, 2016
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Kuai'an nucleic acid amplification reaction reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d46e9ed7cb6f5d5279dddc599037fe93 and manufactured by QIAGEN GMBH. The authorized representative in Taiwan is TAIGEN BIOSCIENCE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices